{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:34:47Z","timestamp":1790681687372,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.vaccine.2015.02.075","type":"journal-article","created":{"date-parts":[[2015,3,31]],"date-time":"2015-03-31T07:40:48Z","timestamp":1427787648000},"page":"2367-2378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Cost-effectiveness of rabies post-exposure prophylaxis in the context of very low rabies risk: A decision-tree model based on the experience of France"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6139-5315","authenticated-orcid":false,"given":"Florence","family":"Ribadeau Dumas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieynaba S.","family":"N\u2019Diaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Paireau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Gautret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Bourhy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Le Pen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazdan","family":"Yazdanpanah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.02.075_bib0250","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.trstmh.2008.04.008","article-title":"Viewpoint: management of human rabies","volume":"102","author":"Wilde","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2015.02.075_bib0255","doi-asserted-by":"crossref","first-page":"7140","DOI":"10.1016\/j.vaccine.2010.08.082","article-title":"Rabies vaccines: WHO position paper\u2014recommendations","volume":"28","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.02.075_bib0260","first-page":"1","article-title":"Human rabies prevention\u2014United States, 2008: recommendations of the Advisory Committee on Immunization Practices","volume":"57","author":"Manning","year":"2008","journal-title":"MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep Cent Dis Control"},{"key":"10.1016\/j.vaccine.2015.02.075_bib0265","first-page":"1","article-title":"WHO Expert Consultation on Rabies","year":"2013","journal-title":"World Health Organ Tech Rep Ser"},{"key":"10.1016\/j.vaccine.2015.02.075_bib0270","unstructured":"Veritas DN. Interpretation of Rabies Risk Assessment: Final Report. Report for Defra (UK) 2011. \u3008http:\/\/citeseerx.ist.psu.edu\/viewdoc\/download?doi=10.1.1.394.8967&rep=rep1&type=pdf\u3009 [accessed 19.05.14]."},{"key":"10.1016\/j.vaccine.2015.02.075_bib0275","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1111\/j.1539-6924.2012.01804.x","article-title":"A quantitative release assessment for the noncommercial movement of companion animals: risk of rabies reintroduction to the United Kingdom","volume":"32","author":"Goddard","year":"2012","journal-title":"Risk Anal"},{"key":"10.1016\/j.vaccine.2015.02.075_bib0280","first-page":"1","article-title":"WHO Expert Consultation on Rabies","author":"World Health Organization","year":"2005","journal-title":"World Health Organ Tech Rep Ser"},{"key":"10.1016\/j.vaccine.2015.02.075_bib0285","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1051\/medsci\/2013291013","article-title":"Rabies","volume":"29","author":"Ribadeau-Dumas","year":"2013","journal-title":"M\u00e9decine\/Sciences"},{"key":"10.1016\/j.vaccine.2015.02.075_bib0290","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1136\/bmj.1.6017.1066","article-title":"Dog bites and rabies: an assessment of risk","volume":"1","author":"Robinson","year":"1976","journal-title":"Br Med J"},{"key":"10.1016\/j.vaccine.2015.02.075_bib0295","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1056\/NEJMcp042140","article-title":"Clinical practice. Prophylaxis against rabies","volume":"351","author":"Rupprecht","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.02.075_bib0300","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1086\/598998","article-title":"Bats in the bedroom, bats in the belfry: reanalysis of the rationale for rabies postexposure prophylaxis","volume":"48","author":"Serres","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2015.02.075_bib0305","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.tmaid.2008.05.003","article-title":"Rabies vaccination and traffic accidents","volume":"6","author":"Gunther","year":"2008","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.vaccine.2015.02.075_bib0310","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3201\/eid1502.080637","article-title":"European bat lyssavirus transmission among cats, Europe","volume":"15","author":"Dacheux","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2015.02.075_bib0315","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1007\/s00705-013-1747-y","article-title":"Isolation of Bokeloh bat lyssavirus in Myotis nattereri in France","volume":"158","author":"Picard-Meyer","year":"2013","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2015.02.075_bib0320","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S0264-410X(02)00586-8","article-title":"Human rabies prophylactics: the French experience","volume":"21","author":"Rotivel","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.02.075_bib0325","unstructured":"Health Protection Agency. Rabies risks in terrestrial animals, by country. \u3008http:\/\/www.hpa.org.uk\/web\/HPAweb&HPAwebStandard\/HPAweb_C\/1259152458758\u3009 [accessed 28.02.14]."},{"key":"10.1016\/j.vaccine.2015.02.075_bib0330","unstructured":"World Health Organization. International travel and health. Vaccine-preventable diseases and vaccine. WHO 2012. \u3008http:\/\/www.who.int\/ith\/fr\/\u3009 [accessed 04.04.14]."},{"key":"10.1016\/j.vaccine.2015.02.075_bib0335","unstructured":"Comit\u00e9 technique des vaccinations. Direction G\u00e9n\u00e9rale de la Sant\u00e9. Guide des vaccinations 2012. INPES 2012. \u3008http:\/\/www.inpes.sante.fr\/nouveautes-editoriales\/2012\/guide-vaccination-2012.asp\u3009 [accessed 28.02.14]."},{"key":"10.1016\/j.vaccine.2015.02.075_bib0340","first-page":"1","article-title":"Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices","volume":"59","author":"Rupprecht","year":"2010","journal-title":"MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep Cent Dis Control"},{"key":"10.1016\/j.vaccine.2015.02.075_bib0345","unstructured":"Ribadeau-Dumas F, Dacheux L, Bourhy H. Epidemiology of post-exposure prophylaxis against rabies in France. Annual Report 2011. Fr Rabies Natl Ref Cent 2012. \u3008http:\/\/www.pasteur.fr\/ip\/easysite\/pasteur\/fr\/sante\/centres-nationaux-de-reference-et-centres-collaborateurs-de-l-oms\/cnr-et-ccoms\/cnr-de-la-rage\/actualites-rapports\u3009 [accessed 28.02.14]."},{"key":"10.1016\/j.vaccine.2015.02.075_bib0350","first-page":"91","volume":"2","author":"Shepard","year":"1996"},{"key":"10.1016\/j.vaccine.2015.02.075_bib0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tmaid.2011.12.005","article-title":"Current rabies vaccines and prophylaxis schedules: preventing rabies before and after exposure","volume":"10","author":"Warrell","year":"2012","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.vaccine.2015.02.075_bib0360","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/S0264-410X(98)00447-2","article-title":"Rabies\u2014risk of exposure and current trends in prevention of human cases","volume":"17","author":"Haupt","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.02.075_bib0365","article-title":"Recommandations relatives \u00e0 la vaccination antirabique pr\u00e9ventive au traitement post-exposition et au suivi s\u00e9rologique des personnes r\u00e9guli\u00e8rement expos\u00e9es aux virus de la rage des chauves-souris en France m\u00e9tropolitaine","author":"Lafeuille","year":"2005","journal-title":"Cons Sup\u00e9r Hygi\u00e8ne Publique Fr"},{"key":"10.1016\/j.vaccine.2015.02.075_bib0370","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s15010-007-6277-7","article-title":"Adverse effects of rabies pre- and postexposure prophylaxis in 290 health-care-workers exposed to a rabies infected organ donor or transplant recipients","volume":"35","author":"Mattner","year":"2007","journal-title":"Infection"},{"key":"10.1016\/j.vaccine.2015.02.075_bib0375","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.tmaid.2014.03.004","article-title":"Adverse events following rabies post-exposure prophylaxis: a comparative study of two different schedules and two vaccines","volume":"12","author":"Sari","year":"2014","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.vaccine.2015.02.075_bib0380","unstructured":"Observatoire National Interminist\u00e9riel de la S\u00e9curit\u00e9 Routi\u00e8re (ONISR). Bilan annuel 2010 de la s\u00e9curit\u00e9 routi\u00e8re en France. \u3008http:\/\/www.securite-routiere.gouv.fr\/la-securite-routiere\/l-observatoire-national-interministeriel-de-la-securite-routiere\/bilans-annuels\/bilans-annuels-de-la-securite-routiere-en-france\u3009.[accessed 28.02.14]."},{"key":"10.1016\/j.vaccine.2015.02.075_bib0385","unstructured":"Agence Technique de l\u2019Information sur l\u2019Hospitalisation (ATIH). R\u00e9f\u00e9rentiel de co\u00fbts MCO 2010. \u3008http:\/\/www.atih.sante.fr\/referentiel-de-couts-mco-2010\u3009 [accessed 08.04.14]."},{"key":"10.1016\/j.vaccine.2015.02.075_bib0390","first-page":"247","article-title":"The cost of rabies postexposure prophylaxis: one state's experience","volume":"113","author":"Kreindel","year":"1998","journal-title":"Public Health Rep Wash DC 1974"},{"key":"10.1016\/j.vaccine.2015.02.075_bib0395","doi-asserted-by":"crossref","first-page":"e1391","DOI":"10.1371\/journal.pntd.0001391","article-title":"Dog Bites in humans and estimating human rabies mortality in rabies endemic areas of Bhutan","volume":"5","author":"Tenzin Dhand","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2015.02.075_bib0400","first-page":"797","article-title":"Prevention of human rabies","volume":"10","author":"Baltazard","year":"1954","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2015.02.075_bib0405","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1001\/jama.1974.03230170023005","article-title":"Postexposure rabies prophylaxis with human rabies immune globulin","volume":"227","author":"Hattwick","year":"1974","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.vaccine.2015.02.075_bib0410","first-page":"789","article-title":"Phenolized vaccine treatment of people exposed to rabies in Southern India","volume":"10","author":"Veeraraghavan","year":"1954","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2015.02.075_bib0415","first-page":"845","article-title":"Can man be protected against rabies?","volume":"10","author":"Meyer","year":"1954","journal-title":"Bull World Health Organ"},{"issue":"3 (Jun)","key":"10.1016\/j.vaccine.2015.02.075_bib0420","first-page":"382","article-title":"Kasuistik zum Lyssa-Problem","volume":"4","author":"Gremliza","year":"1953","journal-title":"Z Tropenmed Parasitol"},{"key":"10.1016\/j.vaccine.2015.02.075_bib0425","first-page":"185","volume":"25","author":"Remlinger","year":"1947","journal-title":"Arch Inst Pasteur Alg\u00e9r Inst Pasteur Alg\u00e9r"},{"key":"10.1016\/j.vaccine.2015.02.075_bib0430","first-page":"283","article-title":"The results of rabies vaccination of man after wolf bite","volume":"3","author":"Nikolic","year":"1952","journal-title":"Z F\u00fcr Tropenmedizin Parasitol"},{"key":"10.1016\/j.vaccine.2015.02.075_bib0435","first-page":"24","article-title":"Eradication de la rage et risque r\u00e9siduel en France m\u00e9tropolitaine","volume":"42","author":"Ribadeau-Dumas","year":"2012","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.vaccine.2015.02.075_bib0440","unstructured":"The European Pet Food Industy. Facts and figures 2012. \u3008http:\/\/www.fediaf.org\/facts-figures\/\u3009 [accessed 28.02.14]."},{"key":"10.1016\/j.vaccine.2015.02.075_bib0445","unstructured":"Institut national de la statistique et des \u00e9tudes \u00e9conomiques: INSEE. Life expectancy detailed by age in 2008\u20132010 in Metropolitan France. 2011. [December 14.12.12]; Available from: \u3008http:\/\/www.insee.fr\/fr\/themes\/tableau.asp?reg_id=0&ref_id=NATnon02229. n.d\u3009."},{"key":"10.1016\/j.vaccine.2015.02.075_bib0450","series-title":"National burden of diseases studies: a practical guide","author":"Mathers","year":"2001"},{"key":"10.1016\/j.vaccine.2015.02.075_bib0455","doi-asserted-by":"crossref","first-page":"e982","DOI":"10.1371\/journal.pntd.0000982","article-title":"Evaluation of cost-effective strategies for rabies post-exposure vaccination in low-income countries","volume":"5","author":"Hampson","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2015.02.075_bib0460","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1016\/j.vaccine.2008.05.048","article-title":"Cost effectiveness of rabies post exposure prophylaxis in the United States","volume":"26","author":"Dhankhar","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.02.075_bib0465","doi-asserted-by":"crossref","first-page":"7167","DOI":"10.1016\/j.vaccine.2009.09.027","article-title":"Evaluating the cost-effectiveness of rabies post-exposure prophylaxis: a case study in Tanzania","volume":"27","author":"Shim","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.02.075_bib0470","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.vaccine.2005.03.059","article-title":"Cost comparison of rabies pre-exposure vaccination with post-exposure treatment in Thai children","volume":"24","author":"Chulasugandha","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.02.075_bib0475","first-page":"122","article-title":"Cost-effectiveness of rabies post exposure prophylaxis in Iran","volume":"14","author":"Hatam","year":"2013","journal-title":"J Res Health Sci"},{"key":"10.1016\/j.vaccine.2015.02.075_bib0480","doi-asserted-by":"crossref","first-page":"e1001463","DOI":"10.1371\/journal.pmed.1001463","article-title":"Modern medicine is neglecting road traffic crashes","volume":"10","author":"Redelmeier","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2015.02.075_bib0485","doi-asserted-by":"crossref","first-page":"e1000366","DOI":"10.1371\/journal.pmed.1000366","article-title":"Prescription medicines and the risk of road traffic crashes: a French registry-based study","volume":"7","author":"Orriols","year":"2010","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2015.02.075_bib0490","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1863-2378.2011.01416.x","article-title":"Risk factors for human rabies in China","volume":"59","author":"Gong","year":"2012","journal-title":"Zoonoses Public Health"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15002868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15002868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T21:57:40Z","timestamp":1537739860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15002868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":49,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0264410X15002868"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.02.075","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness of rabies post-exposure prophylaxis in the context of very low rabies risk: A decision-tree model based on the experience of France","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.02.075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}